このエントリーをはてなブックマークに追加


ID 65530
FullText URL
Author
Matsuo, Toshihiko Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University ORCID Kaken ID publons researchmap
Hiramatsu‐Asano, Sumie Department of Rheumatology, Kawasaki Medical School
Sawachika, Hiroshi Department of Rheumatology, Kawasaki Medical School
Nishimura, Hirotake Department of Pathology, Kawasaki Medical School
Abstract
Key Clinical Message: Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, specifically with myeloperoxidase (MPO)-ANCA, would have a risk for developing corneal melt and perforation abruptly in a short period. It is desirable to have a team of collaboration of rheumatologists and other specialties.
Abstract: An 80-year old man who had been diagnosed 5.5 years previously as ANCA-associated vasculitis by temporal artery biopsy developed corneal melt and perforation with scleritis in both eyes. He underwent successful cataract surgery and retained ambulatory vision with the aid of intravenous rituximab. Two additional patients with similar manifestations were found in the literature.
Keywords
ANCA-associated vasculitis
corneal melt and perforation
rituximab
scleritis
temporal artery biopsy
Published Date
2023-06-20
Publication Title
Clinical Case Reports
Volume
volume11
Issue
issue6
Publisher
Wiley
Start Page
e7595
ISSN
2050-0904
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2023 The Authors.
File Version
publisher
PubMed ID
DOI
Related Url
isVersionOf https://doi.org/10.1002/ccr3.7595
License
http://creativecommons.org/licenses/by-nc/4.0/
Citation
Matsuo T, Hiramatsu-Asano S, Sawachika H, Nishimura H. ANCA-associated vasculitis with scleritis, corneal melt, and perforation rescued by rituximab: Case report and literature review. Clin Case Rep. 2023;11:e7595. doi:10.1002/ccr3.7595